c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes.
Epidermal growth factor receptor (EGFR) controls cell growth and has a key role in tumorigenic processes. The extent of EGFR signaling is tightly regulated by post-transcriptional modifications leading to down-regulation of the levels of the receptor. Previous studies from our laboratory demonstrated that the reactive oxidant hydrogen peroxide activates the EGFR, yet, without down-regulation of the receptor levels, which results in prolonged receptor signaling. In the present study we examined the role of the E3 ligase c-Cbl, as a possible link between oxidative stress, EGFR signaling, and tumorigenic responses. First, we ectopically expressed a mutant EGFR (Tyr-1045 --> Phe) in cells lacking endogenous receptor, to determine whether the lack of phosphorylation at this site is the cause for EGFR retention at the membrane under oxidative stress, as we have previously suggested. Our findings suggest that abrogation of tyrosine 1045 phosphorylation alone is not enough to retain the EGFR at the plasma membrane under oxidative stress. Second, through the use of the Src inhibitor PP1, our findings establish EGFR movement out of the early endosomes as the exact location where c-Cbl-mediated ubiquitinylation is essential for EGFR trafficking. Finally, our studies substantiate the findings that c-Cbl-mediated ubiquitinylation is needed for degradation, but not for internalization of the EGFR in both transfection-dependent Chinese hamster ovary cells and transfection-independent A549 lung epithelial cells. These findings only begin to explain the features seen under oxidative stress, but they yield a greater understanding of the role of c-Cbl in EGFR trafficking.
Ravid
Tommer
T
Signal Transduction, Department of Internal Medicine, University of California, School of Medicine, Davis, CA 95616, USA.
Heidinger
Jill M
JM
Gee
Peter
P
Khan
Elaine M
EM
Goldkorn
Tzipora
T
D000818:Animals; D015153:Blotting, Western; D016466:CHO Cells; D045744:Cell Line, Tumor; D006224:Cricetinae; D015536:Down-Regulation; D011992:Endosomes / Q000378:metabolism*; D066246:ErbB Receptors / Q000378:metabolism*; D006801:Humans; D006861:Hydrogen Peroxide / Q000737:chemistry; D008856:Microscopy, Fluorescence; D008954:Models, Biological; D009154:Mutation; D018384:Oxidative Stress; D010649:Phenylalanine / Q000737:chemistry; D010749:Phosphoprotein Phosphatases / Q000378:metabolism; D011233:Precipitin Tests; D021381:Protein Transport; D011518:Proto-Oncogene Proteins / Q000378:metabolism*; D050721:Proto-Oncogene Proteins c-cbl; D012323:RNA Processing, Post-Transcriptional; D015398:Signal Transduction; D014162:Transfection; D014443:Tyrosine / Q000737:chemistry; D025801:Ubiquitin / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*
D011518:Proto-Oncogene Proteins; D025801:Ubiquitin; D014443:Tyrosine; D010649:Phenylalanine; D006861:Hydrogen Peroxide; D050721:Proto-Oncogene Proteins c-cbl; D044767:Ubiquitin-Protein Ligases; D066246:ErbB Receptors; D010749:Phosphoprotein Phosphatases; C067419:CBL protein, human